Oppenheimer Asset Management Inc. Takeda Pharmaceutical CO LTD Transaction History
Oppenheimer Asset Management Inc.
- $8.4 Billion
- Q2 2025
A detailed history of Oppenheimer Asset Management Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 57,613 shares of TAK stock, worth $811,191. This represents 0.01% of its overall portfolio holdings.
Number of Shares
57,613
Previous 55,466
3.87%
Holding current value
$811,191
Previous $824,000
8.01%
% of portfolio
0.01%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding TAK
# of Institutions
368Shares Held
73.1MCall Options Held
1.68MPut Options Held
157K-
Capital Research Global Investors Los Angeles, CA13.3MShares$187 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.62MShares$107 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.5MShares$63.4 Million0.01% of portfolio
-
Ubs Group Ag4.02MShares$56.7 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.71MShares$52.3 Million0.54% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $43.8B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...